Diabetes and Cardiovascular Disease-Reference-Cited by-同舟云学术

Diabetes and Cardiovascular Disease

Published:2020-12-30 Issue:46 Volume:26 Page:5909-5910
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:CPD

Author:

Siasos Gerasimos¹

Affiliation:

1. 3rd Department of Cardiology, “Sotiria” Hospital University of Athens Medical School Athens, Greece

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Reference39 articles.

1. Salehi B; Ata A; V Anil Kumar N, et al Antidiabetic Potential of Medicinal Plants and Their Active Components. Biomolecules 2019,9,551

2. Fras Z.; Sahebkar A.; Banach M.; The Use of Aspirin in Contemporary Primary Prevention of Atherosclerotic Cardiovascular Diseases Revisited: The Increasing Need and Call for a Personalized Therapeutic Approach. Am J Cardiovasc Drugs In press2020

3. Kollia C.; Antonopoulos A.S.; Siasos G.; Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus? Curr Vasc Pharmacol 2019,17,204-208

4. Gouliopoulos N.; Antonopoulos A.S.; Siasos G.; Macrovascular function indices for the prediction of diabetic retinopathy development in patients with type 2 diabetes. Eur J Prev Cardiol 2017,24,1405-1407

5. Siasos G.; Paschou S.A.; Tousoulis D.; Mitochondria and diabetes. Ann Transl Med 2020,8,262

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of key genes and biological pathways associated with vascular aging in diabetes based on bioinformatics and machine learning;Aging;2024-05-27

2. Efficacy and safety of dapagliflozin combined with insulin in overweight or obese individuals with type 2 diabetes;PAK J PHARM SCI;2023